Suppr超能文献

致病革兰阳性球菌中对β-内酰胺类和糖肽类抗生素耐药和耐受的机制。

Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci.

机构信息

Department of Medical Microbiology, Chalubinskiego 5, 02-004 Warsaw, Medical University of Warsaw, Poland.

出版信息

Mini Rev Med Chem. 2009 Nov 1;9(13):1527-37. doi: 10.2174/138955709790361557.

Abstract

Beta-lactams are the most frequently used antimicrobials in combating infections. In the case of gram-positive bacteria resistant to beta-lactams, glycopeptides are the first choice. The occurrence, mechanisms and genetic background of the resistance of pathogenic staphylococci, streptococci and enterococci to beta-lactam and glycopeptide antibiotics were discussed. The resistances to well-established antimicrobials, as well as new agents (ceftobiprole, oritavancin, telavancin, dalbavancin) were taken into consideration in the text.

摘要

β-内酰胺类抗生素是抗感染治疗中最常用的抗菌药物。对于耐β-内酰胺类抗生素的革兰阳性菌,糖肽类抗生素是首选药物。本文讨论了致病性葡萄球菌、链球菌和肠球菌对β-内酰胺类和糖肽类抗生素产生耐药性的发生、机制和遗传背景。文中还考虑了对现有抗菌药物以及新型药物(头孢洛林、奥他万古、替拉万星、达巴万星)的耐药性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验